More is less: Systemic treatment for local control in soft tissue sarcoma

Annals of Surgical Oncology

Volumn 8, Issue 6, 2001, Pages 480-481

  Brennan, M F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; EDITORIAL; HUMAN; RISK FACTOR; SOFT TISSUE SARCOMA; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; CISPLATIN; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; RADIOTHERAPY, ADJUVANT; SOFT TISSUE NEOPLASMS;

EID: 0034938081     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.6.480     Document Type: Editorial

References (2)

1. Survival following induction chemotherapy and surgical resection for high-grade extremity sarcoma. Is radiation necessary?
2. Long-term results of a prospective randomized trial evaluating the role of adjuvant brachytherapy in soft tissue sarcoma